
Topic: Medical: Neurology
The new items published under this topic are as follows.
Anavex Life Sciences Corp. has selected FORENAP Pharma EURL as the contract research organization (CRO)
Posted by
anavex
on
Wednesday, September 30, 2009
Anavex Life Sciences Corp. today announced the completion of scale-up manufacturing of ANAVEX 2-73, its lead compound for the treatment of Alzheimer’s disease.
Posted by
anavex
on
Monday, September 21, 2009
LESLIE MUNZER NEUROLOGICAL INSTITUTE OF LI TO PROVIDE EDUCATIONAL SEMINARS FOR ADULTS AND YOUTH THAT TIE TOGETHER SPORTS WITH HEAD/BRAIN INJURIES
March is Traumatic Brain Injury Awareness Month Throughout The United States
Posted by
smmgerica
on
Wednesday, March 25, 2009
Anavex Life Sciences Corp.(OTCBB: AVXL) today announced the appointment of Dr. Mark A. Smith
Posted by
anavex
on
Tuesday, February 10, 2009
Anavex Life Sciences Corp., (“ANAVEX”) (OTCBB: AVXL) has signed an agreement with organic chemistry services provider Syntagon AB (“Syntagon”) for the scale-up manufacturing of ANAVEX 2-73, its lead compound for the treatment of Alzheimer’s disease.
Posted by
anavex
on
Monday, February 02, 2009
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL)was selected to present its latest results with ANAVEX 1-41 at Neuroscience 2008, the 38th annual meeting of the Society for Neuroscience, which took place November 15-19, 2008 in Washington, DC.
Posted by
anavex
on
Friday, December 05, 2008
Monica Vest Wheeler, an author from central Illinois, announces the release of her new book, “Alzheimer's, Dementia & Memory Loss: Straight Talk for Families & Caregivers.”
Posted by
darcy520
on
Wednesday, July 30, 2008
June 9, 2008 - A new treatment regime for children with cerebral palsy and other developmental disabilities has been developed by Snowdrop Child Development consultants. The treatment is called ‘neuro-cognitive therapy’ and is presented in the form of a programme, which families carry out at home for several hours per day.
Posted by
brere1
on
Monday, June 09, 2008